Presenter: A. Eggermont
Alexander Eggermont is the Director General of the Cancer Institute Gustave Roussy, Villejuif-Paris, France. He is Professor of Surgical Oncology and Professor of International Networking in Cancer Research at the Erasmus University Medical Centre in Rotterdam. He holds the ‘Joseph Maisin Chair in Oncology at the Catholic University of Leuven in Belgium. In 1987 he obtained his PhD on ‘Interferon and IFN-Inducers in the Treatment of Cancer’ at the Erasmus University Rotterdam and is a former Fellow of the NCI Surgery Branch, NIH, Bethesda, USA.
His clinical specialties include melanoma, sarcoma and regional therapy techniques as well as general drug development and clinical trial methodology. He is a past Chair of the EORTC MG Group and current Chair of the Adjuvant Therapy Committee EORTC Melanoma Group. His basic research field is in tumor immunology, advanced imaging models and tumor pathophysiology.
Professor Eggermont is the author or co-author of over 600 peer-reviewed publications, book chapters and monographs. More than 30 PhD theses have originated in his clinical and basic laboratory research programs at the Erasmus University MC Rotterdam.